CEO is indeed head down bum up managing the RePosa stageII OSA 42X underway
'Phase 2 of the RePOSA study will be conducted at 25 sites in the United States. Phase 3 will extend the study to 30 additional sites across the EU and UK.'
30 million osa sufferers across the US alone - only 6 million diagnosed within that cohort - not really much of a market ..
- Forums
- ASX - By Stock
- IHL
- General discussion
General discussion, page-19953
-
-
- There are more pages in this discussion • 495 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)